Seth Loring Harrison - Net Worth and Insider Trading
Seth Loring Harrison Net Worth
The estimated net worth of Seth Loring Harrison is at least $212 Million dollars as of 2024-04-23. Seth Loring Harrison is the Director, 10% Owner of Stoke Therapeutics Inc and owns about 17,161,713 shares of Stoke Therapeutics Inc (STOK) stock worth over $198 Million. Seth Loring Harrison is the Director of Heartware International Inc and owns about 139,143 shares of Heartware International Inc (HTWR) stock worth over $8 Million. Seth Loring Harrison is also the Director of Akero Therapeutics Inc and owns about 284,364 shares of Akero Therapeutics Inc (AKRO) stock worth over $6 Million. Details can be seen in Seth Loring Harrison's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Seth Loring Harrison has not made any transactions after 2022-11-30 and currently still holds the listed stock(s).
Transaction Summary of Seth Loring Harrison
Seth Loring Harrison Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Seth Loring Harrison owns 6 companies in total, including Akero Therapeutics Inc (AKRO) , Stoke Therapeutics Inc (STOK) , and Heartware International Inc (HTWR) among others .
Click here to see the complete history of Seth Loring Harrison’s form 4 insider trades.
Insider Ownership Summary of Seth Loring Harrison
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2022-11-30 | director |
| STOK | Stoke Therapeutics Inc | 2020-11-24 | director & 10 percent owner |
| HTWR | Heartware International Inc | 2016-08-23 | director |
| ELDN | Eledon Pharmaceuticals Inc | 2014-09-16 | director & 10 percent owner |
| AVTX | Avalo Therapeutics Inc | 2015-10-14 | director & 10 percent owner |
| TTNP | Titan Pharmaceuticals Inc | 2013-11-25 | 10 percent owner |
Seth Loring Harrison Latest Holdings Summary
Seth Loring Harrison currently owns a total of 3 stocks. Among these stocks, Seth Loring Harrison owns 17,161,713 shares of Stoke Therapeutics Inc (STOK) as of November 24, 2020, with a value of $198 Million and a weighting of 93.38%. Seth Loring Harrison owns 139,143 shares of Heartware International Inc (HTWR) as of January 6, 2014, with a value of $8 Million and a weighting of 3.8%. Seth Loring Harrison also owns 284,364 shares of Akero Therapeutics Inc (AKRO) as of November 30, 2022, with a value of $6 Million and a weighting of 2.82%.
Latest Holdings of Seth Loring Harrison
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2020-11-24 | 17,161,713 | 11.54 | 198,046,168 |
| HTWR | Heartware International Inc | 2014-01-06 | 139,143 | 57.98 | 8,067,511 |
| AKRO | Akero Therapeutics Inc | 2022-11-30 | 284,364 | 21.03 | 5,978,753 |
Holding Weightings of Seth Loring Harrison
Seth Loring Harrison Form 4 Trading Tracker
According to the SEC Form 4 filings, Seth Loring Harrison has made a total of 2 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Stoke Therapeutics Inc is the acquisition of 375,000 shares on November 24, 2020, which cost Seth Loring Harrison around $15 Million.
According to the SEC Form 4 filings, Seth Loring Harrison has made a total of 0 transactions in Heartware International Inc (HTWR) over the past 5 years. The most-recent trade in Heartware International Inc is the sale of 7,909 shares on January 6, 2014, which brought Seth Loring Harrison around $785,285.
According to the SEC Form 4 filings, Seth Loring Harrison has made a total of 5 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 23,131 shares on November 30, 2022, which brought Seth Loring Harrison around $1 Million.
Insider Trading History of Seth Loring Harrison
- 1
Seth Loring Harrison Trading Performance
GuruFocus tracks the stock performance after each of Seth Loring Harrison's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seth Loring Harrison is -1.56%. GuruFocus also compares Seth Loring Harrison's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seth Loring Harrison within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Seth Loring Harrison's insider trading performs compared to the benchmark.
Performance of Seth Loring Harrison
Average Return
-15.36%
Outperforming Transactions
25%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.62 | -1.56 | -6.51 | -15.36 | -16.15 | -23.01 |
| Relative Return to S&P 500(%) | 2.93 | -6.38 | -20.05 | -34.12 | -30.13 | -32.42 |
Seth Loring Harrison Ownership Network
Ownership Network List of Seth Loring Harrison
Ownership Network Relation of Seth Loring Harrison
Seth Loring Harrison Owned Company Details
What does Akero Therapeutics Inc do?
Who are the key executives at Akero Therapeutics Inc?
Seth Loring Harrison is the director of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Operating Officer Jonathan Young , director & President & CEO Andrew Cheng , and Chief Development Officer Catriona Yale .
Akero Therapeutics Inc (AKRO) Insider Trades Summary
Over the past 18 months, Seth Loring Harrison made 3 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 352,721. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 353,870 shares made by Andrew Cheng , a net sale of 76,975 shares made by Jonathan Young , and a net sale of 82,268 shares made by Catriona Yale .
In summary, during the past 3 months, insiders sold 105,332 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 105,332 shares. During the past 18 months, 2,736,073 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net sale of 1,416,073 shares.
Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akero Therapeutics Inc Insider Transactions
Seth Loring Harrison Mailing Address
Above is the net worth, insider trading, and ownership report for Seth Loring Harrison. You might contact Seth Loring Harrison via mailing address: 230 Park Avenue, Suite 2800, New York Ny 10169.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
